Plasma osteopontin is not associated with vascular markers of subclinical atherosclerosis in a population of young adults without symptoms of cardiovascular disease. The Cardiovascular Risk in Young Finns Study

References

• Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, Murphy SA, . Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006;113:38–43.
   PubMed Web of Science ®Google Scholar
• Miller M, Zhan M, Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Intern Med 2005;165:2063–8.
   PubMedGoogle Scholar
• Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Inflammation in peripheral artery disease. Circulation 2010;122: 1862–75.
   PubMed Web of Science ®Google Scholar
• Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H, Ohsuzu F. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003;170:333–7.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Cho HJ, Kim HS. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep 2009;11: 206–13.
   PubMed Web of Science ®Google Scholar
• Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007;27: 2302–9.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 1994; 94:1597–1604.
   PubMed Web of Science ®Google Scholar
• Momiyama Y, Ohmori R, Fayad ZA, Kihara T, Tanaka N, Kato R, . Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis. Atherosclerosis 2010;210:668–70.
   PubMed Web of Science ®Google Scholar
• Waller AH, Sanchez-Ross M, Kaluski E, Klapholz M. Osteopontin in cardiovascular disease: a potential therapeutic target. Cardiol Rev 2010;18:125–31.
   PubMedGoogle Scholar
• Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, . Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003;290:2277–83.
   PubMed Web of Science ®Google Scholar
• Juonala M, Viikari JS, Kähönen M, Solakivi T, Helenius H, Jula A, . Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the Cardiovascular Risk in Young Finns Study. J Am Coll Cardiol 2008;52: 293–9.
   PubMed Web of Science ®Google Scholar
• Kurata M, Okura T, Watanabe S, Fukuoka T, Higaki J. Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci (Lond) 2006;111: 319–24.
   PubMed Web of Science ®Google Scholar
• Telama R, Yang X, Viikari J, Välimäki I, Wanne O, Raitakari O. Physical activity from childhood to adulthood: a 21-year tracking study. Am J Prev Med 2005;28:267–73.
   PubMed Web of Science ®Google Scholar
• Raiko JR, Viikari JS, Ilmanen A, Hutri-Kähönen N, Taittonen L, Jokinen E, . Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors. J Intern Med 2010;267: 370–84.
   PubMed Web of Science ®Google Scholar
• Saarikoski LA, Huupponen RK, Viikari JS, Marniemi J, Juonala M, Kähönen M, Raitakari OT. Adiponectin is related with carotid artery intima-media thickness and brachial flow-mediated dilatation in young adults – the Cardiovascular Risk in Young Finns Study. Ann Med 2010; 42:603–11.
   PubMed Web of Science ®Google Scholar
• Juonala M, Viikari JSA, Laitinen T, Marniemi J, Helenius H, Rönnemaa T, Raitakari OT. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults. The Cardiovascular Risk in Young Finns Study. Circulation 2004;110:2918–23.
   PubMed Web of Science ®Google Scholar
• Ishiyama M, Suzuki E, Katsuda J, Murase H, Tajima Y, Horikawa Y, . Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients. Diabetes Res Clin Pract 2009;85: 189–96.
   PubMed Web of Science ®Google Scholar
• Pepys MD. C-reactive protein. In: Delves PJ, Roitt IM, editors. Encyclopedia of immunology, 2nd ed. San Diego, CA: Academic Press, 1988. pp. 663–5.
   Google Scholar
• Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805–12.
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Karbstein P, Markus HS, Sitzer M. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke 2007;38:1774–9.
   PubMedGoogle Scholar
• Nordestgaard BG, Zachoa J. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander? Nutrition, Metabolism Cardiovasc Dis 2009;19:521–4.
   PubMed Web of Science ®Google Scholar
• Abdel-Azeez HA, Al-Zaky M. Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis. J Clin Lab Anal 2010;24:201–6.
   PubMedGoogle Scholar
• Calderon-Margalit R, Schwartz SM, Wellons MF, Lewis CE, Daviglus ML, . Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the ‘Coronary Artery Risk Development in Young Adult Women's study. J Clin Endocrinol Metab 2010;95:4424–31.
   PubMed Web of Science ®Google Scholar
• Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol 2011;40:189–207.
   PubMed Web of Science ®Google Scholar
• Kurata M, Okura T, Irita J, Enomoto D, Nagao T, Jotoku M, Miyoshi K, Higaki J. The relationship between osteopontin and adiponectin in patients with essential hypertension. Clin Exp Hypertens 2010;32:358–63.
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459–67.
   PubMed Web of Science ®Google Scholar
• Georgiadou P, Iliodromitis EK, Kolokathis F, Varounis C, Gizas V, Mavroidis M, . Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study. Eur J Clin Invest 2010;40:288–93.
   PubMed Web of Science ®Google Scholar